.
MergerLinks Header Logo

New Deal


Announced

DKSH to acquire Refarmed Group.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Acquisition

Pending

Pharmaceuticals

Friendly

Switzerland

Majority

Single Bidder

pharmaceuticals

Cross Border

Private

Synopsis

Edit

DKSH, a market expansion services provider, agreed to acquire Refarmed Group, an operator of a pharmaceutical platform. Financial terms were not disclosed. “We are excited to strengthen our capabilities in Life Sciences by teaming up with a trusted player with strong expertise. Refarmed’s products and services complement our existing portfolio and increases our access Pharma industries. We welcome all Refarmed employees and look forward to continuing to grow the business together with them," Thomas Sul and Natale Capri, DKSH Co-Heads of Business Unit Performance Materials.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US